IPO Edge hosted a fireside chat with Conexeu Sciences Inc. (Nasdaq: CNXU) President and Chief Executive Officer Miles Harrison, moderated by IPO Edge Editor-in-Chief John Jannarone and Editor-at-Large Jarrett Banks in a video session lasting approximately 30 minutes. Mr. Harrison discussed:How the company is developing tissue-regeneration technology for wound care, aesthetics, oral health, veterinary medicine and reconstruction. The company developing a bioresorbable regenerative scaffold as a potential alternative to silicone breast implants. WATCH MOREAbout Conexeu Sciences Inc. (Nasdaq: CNXU)Architecting bioregeneration. Conexeu Sciences is a preclinical-stage regenerative tissue platform company.